Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP42: Impact of discontinuing thiopurines at anti-TNF initiation in Inflammatory Bowel Disease: A nationwide Danish cohort studyECCO'20 Vienna
Year: 2020
Authors: Sandra Bohn Thomsen
DOP43: The risk of extra-intestinal cancer in Inflammatory Bowel Disease (IBD): A systematic review and meta-analysis of population-based cohort studiesECCO'20 Vienna
Year: 2020
Authors: Bobby Zhao Sheng Lo
DOP44: Cancer risk in a high-incidence Inflammatory Bowel Disease population – a Faroese IBD cohort studyECCO'20 Vienna
Year: 2020
Authors: Jóngerð Maria Miné Midjord
DOP45: Increased prevalence but not incidence of myocardial infarction and stroke in patients with Inflammatory Bowel Diseases in Quebec in 1996-2015ECCO'20 Vienna
Year: 2020
Authors: Péter Laszlo Lakatos
DOP47: The changing pattern of Inflammatory Bowel Disease incidence in Northern France: A continuing increase in the young women (1988-2014)ECCO'20 Vienna
Year: 2020
Authors: Corinne Gower Rousseau
DOP48: Gene expression landscape of epithelial monolayer in Inflammatory Bowel DiseaseECCO'20 Vienna
Year: 2020
Authors: Atle Granlund Van Beelen
DOP49: Quantitative proteomics analysis of macrophages from Crohn’s Disease patients and infected with adherent-invasive Escherichia coliECCO'20 Vienna
Year: 2020
Authors: Anthony Buisson
DOP50: The landscape of somatic mutations in non-neoplastic IBD-affected colonECCO'20 Vienna
Year: 2020
Authors: Carl Anderson
DOP51: Investigation on the role of Par4-associated cell polarity and associated barrier defects in Inflammatory Bowel DiseasesECCO'20 Vienna
Year: 2020
Authors: Federica Branchi
DOP52: The phenotype of NOD-scid IL-2Rγnull mice reconstituted with peripheral blood mononuclear cells from patients with Crohn’s Disease or Ulcerative Colitis reflects the respective diseaseECCO'20 Vienna
Year: 2020
Authors: Anna Unterweger
DOP54: Integrated network analysis using patient-specific single nucleotide polymorphism profiles uncovers new pathways involved in Ulcerative Colitis pathogenesisECCO'20 Vienna
Year: 2020
Authors: Dezso Modos
DOP55: A real-world comparison of the effectiveness and safety of vedolizumab and anti-TNF therapies in early treatment initiation with first-line biologic therapy in Ulcerative Colitis: Results from EVOLVEECCO'20 Vienna
Year: 2020
Authors: Gerassimos Mantzaris
DOP56: Ustekinumab maintained clinically meaningful improvement in health-related quality of life in patients with moderate to severe Ulcerative Colitis: Results from the UNIFI long-term extensionECCO'20 Vienna
Year: 2020
Authors: William Sandborn
DOP57: Vedolizumab has similar efficacy rates in young and elderly patients: A binational, multicenter, retrospective case-control studyECCO'20 Vienna
Year: 2020
Authors: Nathaniel Aviv Cohen
DOP58: Tofacitinib for Ulcerative Colitis: Results of the ICC Registry, a nationwide prospective observational cohort studyECCO'20 Vienna
Year: 2020
Authors: Jasmijn Sleutjes
DOP59: Maintenance of remission with tofacitinib in patients with Ulcerative Colitis: Updated results of a subpopulation analysis from an open-label, long-term extension study, OCTAVE OpenECCO'20 Vienna
Year: 2020
Authors: Walter Reinisch
DOP60: Vedolizumab treatment persistence and safety in an extended access program (XAP)ECCO'20 Vienna
Year: 2020
Authors: Silvio Danese
DOP61: Tofacitinib, an oral, small molecule Janus kinase inhibitor, in the treatment of Ulcerative Colitis: Analysis of an open-label, long-term extension study with up to 5.9 years of treatmentECCO'20 Vienna
Year: 2020
Authors: Donna Judd
DOP62: Morbidity after primary ileocecal resection for Crohn’s Disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centreECCO'20 Vienna
Year: 2020
Authors: Matteo Rottoli
DOP63: Efficacy and safety of iron carboxymaltose on chronic fatigue in patients with Inflammatory Bowel Disease: A randomized controlled trialECCO'20 Vienna
Year: 2020
Authors: Gionata Fiorino